...Saniona AB (SSE:SANION) said data from an exploratory Phase IIa trial evaluating once-daily Tesomet tesofensine/metoprolol in... ...the endpoint. Tesomet is a fixed-dose combination of tesofensine, a triple monoamine reuptake inhibitor, and metoprolol... ...a selective adrenergic receptor beta 1 (ADRB1) blocker. Saniona AB (SSE:SANION), Ballerup, Denmark Product: Tesomet tesofensine/metoprolol...
...S.p.A. (Milan:REC) European commercial rights to Selokenmetoprolol tartrate, Seloken ZOK metoprolol succinate and Logimax metoprolol... ...front. AstraZeneca will manufacture and supply the products and is eligible to receive double-digit royalties. Seloken... ...blocker marketed to treat hypertension, angina and heart failure. Logimax, a fixed-dose combination of metoprolol...
...Phase IIa trial in 60 Type II diabetics showed that 0.5 mg/100 mg oral Tesomet tesofensine/metoprolol... ...restlessness reported as the most common adverse events. Saniona AB (SSE:SANION), Ballerup, Denmark Product: Tesomet tesofensine/metoprolol... ...1 ( ADRB1 ) Description: Fixed-dose combination of tesofensine, a triple monoamine reuptake inhibitor, and metoprolol...